Return to Home Mortality > Table > Data Table

Data Table for Rate/Trend Comparison by State/County

Death Rate/Trend Comparison by State/County, 2016-2020

Minnesota versus United States

All Races, Both Sexes

Sorted by count
Cancer Site and Sex
 sort alphabetically by cancer site ascending
Priority Index1
1=highest
9=lowest

 sort by priority index descending
Recent Trend2
County Death
Rate
Compared
to
US Rate
Average Annual Count
 sort by count ascending
Age-Adjusted Death Rate

deaths per 100,000
(95% Confidence Interval)
 sort by rate descending
Rate
Ratio3
County
to
US
 sort by rate descending
Recent 5-Year Trend2 in Death Rates
(95% Confidence Interval)
 sort by trend descending
Lung & Bronchus (Male) 8 falling falling trend similar 1,144 36.1 (35.2, 37.1) 0.9 -5.4 (-6.3, -4.5)
Lung & Bronchus (Female) 8 falling falling trend similar 1,079 28.7 (27.9, 29.5) 1.0 -4.1 (-5.8, -2.3)
Breast (Female) 8 falling falling trend similar 636 17.4 (16.7, 18.0) 0.9 -2.3 (-2.5, -2.1)
Prostate (Male) 6 stable stable trend similar 571 19.6 (18.9, 20.3) 1.0 -0.6 (-2.3, 1.1)
Colon & Rectum (Male) 8 falling falling trend similar 426 14.0 (13.4, 14.6) 0.9 -2.6 (-2.9, -2.4)
Pancreas (Male) 6 stable stable trend similar 397 12.6 (12.1, 13.2) 1.0 0.2 (-0.1, 0.4)
Colon & Rectum (Female) 8 falling falling trend similar 377 9.9 (9.4, 10.4) 0.9 -2.4 (-2.7, -2.2)
Pancreas (Female) 6 stable stable trend similar 363 9.7 (9.2, 10.1) 1.0 0.2 (0.0, 0.5)
Leukemia (Male) 8 falling falling trend similar 267 9.0 (8.5, 9.5) 1.1 -1.2 (-1.5, -0.9)
Liver & Bile Duct (Male) 3 rising rising trend lower 262 8.0 (7.6, 8.5) 0.8 2.2 (1.8, 2.6)
Esophagus (Male) 6 stable stable trend similar 237 7.3 (6.9, 7.7) 1.1 -0.5 (-1.1, 0.1)
Non-Hodgkin Lymphoma (Male) 5 falling falling trend higher 233 7.8 (7.4, 8.3) 1.2 -2.1 (-2.6, -1.7)
Ovary (Female) 8 falling falling trend similar 220 5.9 (5.6, 6.3) 0.9 -2.9 (-3.6, -2.2)
Bladder (Male) 8 falling falling trend similar 195 6.6 (6.2, 7.1) 0.9 -0.4 (-0.7, -0.1)
Uterus (Corpus & Uterus, NOS) (Female) 2 rising rising trend similar 188 5.0 (4.6, 5.3) 1.0 0.8 (0.4, 1.2)
Leukemia (Female) 8 falling falling trend similar 182 4.8 (4.5, 5.1) 1.1 -1.1 (-1.5, -0.8)
Brain & ONS (Male) 2 rising rising trend similar 181 5.8 (5.4, 6.2) 1.1 0.7 (0.1, 1.3)
Kidney & Renal Pelvis (Male) 8 falling falling trend similar 171 5.5 (5.1, 5.9) 1.1 -0.8 (-1.1, -0.4)
Non-Hodgkin Lymphoma (Female) 8 falling falling trend similar 158 4.0 (3.8, 4.4) 1.0 -3.1 (-3.5, -2.6)
Liver & Bile Duct (Female) 2 rising rising trend similar 144 3.9 (3.6, 4.2) 1.0 2.4 (1.9, 2.9)
Brain & ONS (Female) 8 falling falling trend similar 127 3.7 (3.4, 4.0) 1.0 -0.7 (-1.1, -0.3)
Oral Cavity & Pharynx (Male) 2 rising rising trend similar 112 3.4 (3.1, 3.7) 0.9 1.7 (0.2, 3.3)
Stomach (Male) 9 falling falling trend lower 92 3.0 (2.7, 3.3) 0.8 -3.1 (-3.6, -2.7)
Kidney & Renal Pelvis (Female) 8 falling falling trend similar 83 2.2 (2.0, 2.4) 1.0 -1.3 (-1.9, -0.8)
Melanoma of the Skin (Male) 8 falling falling trend similar 81 2.6 (2.4, 2.9) 0.9 -5.4 (-9.6, -0.9)
Bladder (Female) 8 falling falling trend similar 72 1.8 (1.6, 2.0) 0.9 -0.9 (-1.5, -0.3)
Stomach (Female) 9 falling falling trend lower 60 1.6 (1.4, 1.8) 0.8 -2.7 (-3.2, -2.3)
Melanoma of the Skin (Female) 6 stable stable trend similar 55 1.5 (1.3, 1.7) 1.1 -0.4 (-1.0, 0.2)
Oral Cavity & Pharynx (Female) 8 falling falling trend similar 55 1.4 (1.3, 1.6) 1.0 -0.9 (-1.6, -0.3)
Esophagus (Female) 8 falling falling trend similar 54 1.4 (1.2, 1.6) 1.0 -4.2 (-7.6, -0.7)
Cervix (Female) 9 falling falling trend lower 40 1.2 (1.0, 1.4) 0.5 -1.8 (-2.5, -1.2)
Thyroid (Female) 6 stable stable trend similar 19 0.5 (0.4, 0.6) 1.0 -0.3 (-1.2, 0.6)
Childhood (Ages <20, All Sites) (Male) 8 falling falling trend similar 17 2.3 (1.8, 2.9) 1.0 -1.4 (-2.1, -0.7)
Thyroid (Male) 6 stable stable trend similar 16 0.5 (0.4, 0.6) 1.0 0.7 (-0.5, 1.9)
Childhood (Ages <15, All Sites) (Male) 8 falling falling trend similar 12 2.1 (1.6, 2.8) 1.0 -1.3 (-2.2, -0.3)
Childhood (Ages <15, All Sites) (Female)
**
** lower 7 1.4 (0.9, 1.9) 0.7
**
Childhood (Ages <20, All Sites) (Female)
**
** similar 12 1.7 (1.3, 2.2) 0.8
**
Notes:
Created by statecancerprofiles.cancer.gov on 05/19/2024 9:42 am.

Trend2
     Rising     when 95% confidence interval of average annual percent change is above 0.
     Stable     when 95% confidence interval of average annual percent change includes 0.
     Falling     when 95% confidence interval of average annual percent change is below 0.
Rate Comparison
     Above     when 95% confident the rate is above and Rate Ratio3 > 1.10
     Similar     when unable to conclude above or below with confidence.
     Below     when 95% confident the rate is below and Rate Ratio3 < 0.90

** Data are too sparse to provide stable estimates of annual rates needed to calculate trend.
1 Priority indices were created by ordering from rates that are rising and above the comparison rate to rates that are falling and below the comparison rate.
2 Recent trend in death rates is usually an Average Annual Percent Change (AAPC) based on the APCs calculated by Joinpoint Version 4.8.0.0. Due to data availability issues, the time period and/or calculation method used in the calculation of the trends may differ for selected geographic areas.
3 Rate ratio is the county rate divided by the US rate. Previous versions of this table used one-year rates for states and five-year rates for counties. As of June 2018, only five-year rates are used.
Source: Death data provided by the National Vital Statistics System public use data file. Death rates calculated by the National Cancer Institute using SEER*Stat. Death rates are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). The Healthy People 2020 goals are based on rates adjusted using different methods but the differences should be minimal. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used with mortality data.
Note: When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate. Suppression is used to avoid misinterpretation when rates are unstable.

State Cancer Registries may provide more current or more local data. Data presented on the State Cancer Profiles Web Site may differ from statistics reported by the State Cancer Registries (for more information).
Trend for the following could not be reliably determined due to small number of deaths per year:
Childhood (Ages <15, All Sites) (Female), Childhood (Ages <20, All Sites) (Female)


Interpret Rankings provides insight into interpreting cancer statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data for United States does not include Puerto Rico.

Return to Top